Ofev (nintedanib) — United Healthcare
Idiopathic pulmonary fibrosis
Initial criteria
- Diagnosis of idiopathic pulmonary fibrosis
Reauthorization criteria
- Documentation of positive clinical response to Esbriet therapy
- Documentation of positive clinical response to Ofev therapy
Approval duration
12 months